+1 (315) 215-3225

+1 (315) 215-3225
Ibrance- Drug Insight, 2019
Published Date: February 2019
Report Code: DELV-DRIN-216
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Ibrance Drug Insight 2019

Ibrance- Drug Insight, 2019

Code: DELV-DRIN-216
February 2019
Table of Content
Tables & Figures

DelveInsight's pharmaceuticals report, "Ibrance Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Ibrance covering the historical global sales and also provides the Ibrance sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Ibrance and emerging therapies in this space.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

• A review of the Ibrance, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Reasons to Buy
• Establish a comprehensive understanding of Ibrance
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Ibrance`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Ibrance with DelveInsight`s SWOT analysis

1. DelveInsight Report Introduction
2. Ibrance- Overview
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Regulatory Milestones by Region
• Deals and Partnerships
3. Product Details
4. Ibrance Sales Assessment
• Historical Sales
• Forecasted Sales
5. Patent Details
6. Global API Manufacturers Assessment
• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region
7. Market Competition
8. Emerging Therapies
8.1 Drug 1: Company 1
• Product Description
• Research and Development
• Product Development Activities
9. SWOT Analysis
Consulting Services
About DelveInsight
Contact Us

List for Tables : 

Table 1: Ibrance, Description
Table 2: Product Details
Table 3: Ibrance, Historical Sales till 2018 (in million USD)
Table 4: Ibrance, Forecasted Sales from 2019-2021 (in million USD)
Table 5: Patent Details
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region
Table 8: Ibrance Major Competitors
Table 9: Emerging Therapies

List for Figures : 

Figure 1: Ibrance, Historical Global Sales till 2018 (in million USD)
Figure 2: Ibrance, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: API Manufacturers by country
Figure 4: API Manufacturers by Region

Added to Cart
Electronic (PDF)


This license allows only one user to access the PDF.
Electronic (PDF)


This license allows all the users of an enterprise residing in one location to access the PDF
Electronic (PDF)


This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)


Global Fully-automatic Aseptic Filling Machine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18W3675
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3L4016
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Pharmacy Dispensing Machines Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37N3464
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Biologics Fill and Finish Services Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6U7105
Sun Feb 11 00:00:00 UTC 2024

Add to Cart